Skip to main content

Head and neck cancer guide

Salivary gland cancer: symptoms and treatment

Salivary gland cancer is rare. Most lumps that start in the salivary glands are benign, but some are cancers, so a persistent swelling in the face, jaw, mouth or neck should always be examined. This guide sets out what the glands do, which symptoms matter, the main cancer types, how tests proceed in the UK, how treatment is planned, and why a lump lasting more than three weeks is treated as a reason for urgent referral.

Last checked: 2026-10-04

Key facts

At a glance.

  • How rare

    Cancer Research UK says around 760 people are diagnosed with salivary gland cancer in the UK every year, slightly more men than women.

  • Most lumps are benign

    Most tumours that start in the salivary glands are non-cancerous. Cancer Research UK says 3 in 4 parotid tumours are benign.

  • Main symptom

    A painless lump or swelling in the jaw, cheek, mouth or neck. Face numbness or drooping on one side are other possible signs.

  • Most common type

    Mucoepidermoid carcinoma is the most common type of salivary gland cancer.

  • Who gets it

    Risk increases with age, most people are in their 50s or 60s, and earlier radiation treatment to the head and neck raises the risk.

  • Referral rule

    NHS Greater Glasgow and Clyde primary care guidance says a persistent neck lump of more than 3 weeks should be referred to ENT as urgent, on suspicion of cancer.

The salivary glands and where cancer starts

Saliva keeps the mouth and throat moist, helps us swallow and digest food, protects the teeth and guards against infection. Cancer Research UK says there are three main pairs of major salivary glands and more than 600 minor glands in the lining of the mouth and throat.

The major glands are the parotids, just under the lobes of the ears, the submandibular glands, under each side of the jawbone, and the sublingual glands, under the tongue. Most cancers start in the parotid glands, with the rest in the submandibular, sublingual or minor glands.

Because the glands contain several kinds of cell, many different cancers can arise. The type of cancer is named after the type of cell it started in.

Benign tumours are more common than cancer

Cancer Research UK states that most salivary gland tumours are not cancer. For the parotid gland, 3 in 4 are benign. NHS Greater Glasgow and Clyde guidance, written for GPs, gives similar figures: 80% of parotid tumours and 50% of submandibular tumours are benign.

The commonest benign type is pleomorphic adenoma, usually slow growing. Cancer Research UK says doctors are likely to suggest surgery to remove these because there is a small risk of cancer developing within the tumour, and radiotherapy may be offered if one is likely to return.

The practical point is that a lump cannot be classed by feel alone. Examination, imaging and a sample of cells are needed.

Symptoms

Cancer Research UK lists the possible symptoms as a painless lump or swelling in the jaw, cheek, mouth or neck, numbness in part of the face, drooping on one side of the face from facial palsy, pain in the area of the lump, problems swallowing, difficulty opening the mouth fully, and swelling on one side of the face.

Many of these can be caused by benign tumours or other conditions, but it is important to have unusual symptoms checked. The GP guidance describes how a lump is separated from generalised swelling of a gland: a discrete lump suggests a tumour, while swelling of the whole gland suggests infection or a blocked duct.

Risk factors

Cancer Research UK says the causes are not known, but several factors raise risk. Age is the main one, and most people who develop it are in their 50s or 60s, although the overall risk remains small because the cancer is rare.

Radiation exposure is another. This may be radiotherapy to the head or neck for another cancer such as Hodgkin lymphoma or thyroid cancer, or contact with radioactive substances at work. There is some evidence of risk from radioiodine treatment for thyroid cancer, and radiotherapy for a childhood cancer may increase risk for at least 20 years afterwards.

Family history may play a part, but the charity says the evidence is unclear and it may reflect shared lifestyle rather than inherited genes. There is no national screening programme for salivary gland cancer in the UK.

How it is investigated in the UK

Most people start with a GP, who asks about symptoms, examines the area and may arrange tests. Cancer Research UK says a GP might feel around the jaw and neck, arrange blood tests and a chest X-ray, and then refer to a head and neck specialist. The NHS Greater Glasgow and Clyde guidance advises referral to ENT as urgent if a neck lump persists beyond 3 weeks, and to maxillofacial services for a floor of mouth lesion lasting more than 3 weeks.

Specialists usually arrange a neck ultrasound and a fine needle aspiration, which uses a fine needle and syringe to take cells from the lump for examination under a microscope. The charity says ultrasound or CT may guide the needle for deeper lumps, and a local anaesthetic injection can be used.

Further tests may include CT, PET or MRI scans, and testing for gene and protein changes. A biopsy of tissue is not a common test but may be used for minor salivary gland cancers, and panendoscopy under general anaesthetic may be used for areas that are hard to reach.

The main types

A pathologist identifies the cell type from the sample, and the doctor then explains which gland is affected and the cell type.

Types of salivary gland cancer described by Cancer Research UK
TypeKey points
Mucoepidermoid carcinomaMost common; mostly parotid, also submandibular and minor glands; usually slow growing but sometimes fast
Acinic cell carcinomaSlow growing; usually parotid; tends to affect younger people than most types
Adenoid cystic carcinomaCommon type; usually minor glands but can affect major glands; usually slow growing but can return after treatment
AdenocarcinomaRare; from lining cells of major or minor glands
Carcinoma ex-pleomorphic adenomaMalignant mixed cancer that can develop from a benign pleomorphic adenoma
Rarer typesInclude squamous cell, anaplastic and undifferentiated carcinomas, which tend to occur later in life and grow quickly

Treatment and follow-up

Cancer Research UK says treatment depends on where the cancer is, its size, whether it has spread and your general health. Surgery, radiotherapy and chemotherapy are the main treatments, and targeted drugs or immunotherapy may also be used. You might have one or more of these.

Surgery is the most common treatment, and the operation depends on which gland is involved and how far the cancer has grown. If cancer has spread to lymph nodes, a neck dissection may remove some of them. Possible problems after surgery include changes in eating, talking and appearance, plus infection, blood clots and bleeding.

Chemotherapy may be used for advanced cancer or when surgery or radiotherapy is not possible. After treatment you have regular check-ups, which may include blood tests or scans. Support is available from Cancer Research UK, and a charity, Salivary Gland Cancer UK, supports people with rarer types.

Frequently asked

Questions people ask.

Quick, plain-English answers to the questions we hear most.

  • Is a lump in the salivary gland usually cancer?

    No. Cancer Research UK says most salivary gland tumours are benign, and about 3 in 4 parotid tumours are non-cancerous. Any persistent lump still needs to be checked.

  • What is the main symptom of salivary gland cancer?

    A painless lump or swelling in the jaw, cheek, mouth or neck. Numbness of the face, facial drooping, problems swallowing and difficulty opening the mouth can also occur.

  • How many people get it in the UK?

    Around 760 people are diagnosed each year, according to Cancer Research UK. It is slightly more common in men than women.

  • What is the most common type?

    Mucoepidermoid carcinoma, which starts in the lining cells of the gland and most often develops in the parotid gland.

  • When should a lump be referred urgently?

    NHS Greater Glasgow and Clyde guidance for GPs says a persistent neck lump of more than 3 weeks should be referred to ENT as urgent on suspicion of cancer.

  • How is it diagnosed?

    Usually with a neck ultrasound and fine needle aspiration biopsy, and often CT, MRI or PET scans. A pathologist examines the cells to identify the type.

  • Is there a screening test?

    No. Cancer Research UK says there is no national screening programme for salivary gland cancer in the UK.

  • What treatments are used?

    Surgery is the most common, with radiotherapy, chemotherapy, targeted drugs or immunotherapy used according to the situation. Neck dissection may be needed if lymph nodes are affected.

  • Does radiotherapy to the head or neck raise the risk?

    Yes. Cancer Research UK says earlier radiotherapy for conditions such as Hodgkin lymphoma or thyroid cancer raises risk, and childhood radiotherapy may do so for at least 20 years afterwards.

  • Where can I get support?

    Cancer Research UK offers information and a nurse helpline, and Salivary Gland Cancer UK is a charity for people with rarer salivary gland cancers.

Where this comes from

Sources and checking.

This guide is for information, not medical advice.

Your GP or consultant knows your history and can tell you which parts apply to you. If your symptoms are severe, rapidly worsening, or come with red-flag features, seek urgent medical care. Figures and availability change, so treat them as a guide and confirm with the provider.

Published 2026-10-04, next review 2027-10-04.